Share class: Moderna, Inc.

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A1384,817,811348,169,765 ( 90.48 %) 0 90.48 %

Major shareholders: Moderna, Inc.

NameEquities%Valuation
Baillie Gifford & Co.
11.03 %
42,458,083 11.03 % 1 765 M $
Vanguard Fiduciary Trust Co.
10.45 %
40,226,214 10.45 % 1 673 M $
21,102,316 5.484 % 877 M $
BlackRock Advisors LLC
5.165 %
19,876,023 5.165 % 826 M $
Fidelity Management & Research Co. LLC
4.516 %
17,378,914 4.516 % 723 M $
State Street Corp.
4.378 %
16,847,212 4.378 % 701 M $
11,509,357 2.991 % 479 M $
Thélème Partners LLP
1.878 %
7,226,861 1.878 % 300 M $
Geode Capital Management LLC
1.837 %
7,069,580 1.837 % 294 M $
Wellington Trust Co., NA
1.358 %
5,224,685 1.358 % 217 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
NameEquities%Valuation
Caixa DTVM SA
0.001364 %
104,966 0.001364 % 206 100 $
BTG Pactual WM Gestão de Recursos Ltda.
0.000617 %
47,516 0.000617 % 93 297 $

Breakdown by shareholder type

Institutional55.37%
Individuals9.62%
Other6.31%
State Street Corp.4.38%
Manulife Financial Corp.0.80%
Sumitomo Mitsui Trust Group, Inc.0.42%
Schweizerische Nationalbank0.25%
Governments0.20%
Meitav Investment House Ltd.0.06%
SEI Investments Co.0.06%
Banco Bilbao Vizcaya Argentaria SA0.04%
Corebridge Financial, Inc.0.03%
Skandinaviska Enskilda Banken AB0.02%
Swedbank AB0.02%
Nomura Holdings, Inc.0.01%
The Bank of Nova Scotia0.01%
Financial Gravity Cos., Inc.0.01%
Banque Cantonale Vaudoise0.01%
Unknown22.38%

Based on 1000 largest holdings

Geographical origin of shareholders

United States 41.28%
United Kingdom 18.10%
Individuals 9.62%
Canada 2.29%
Switzerland 1.89%
Norway 0.92%
Japan 0.85%
France 0.50%
Australia 0.47%
Luxembourg 0.32%
South Korea 0.28%
Sweden 0.27%
Ireland 0.13%
Israel 0.11%
Germany 0.11%
Spain 0.09%
China 0.09%
Netherlands 0.06%
Denmark 0.05%
Hong Kong 0.04%
Finland 0.03%
Singapore 0.03%
Czech Republic 0.02%
Belgium 0.02%
Austria 0.01%
South Africa 0.01%
Italy 0.01%
Cayman Islands 0.01%

Based on 1000 largest holdings

Logo Moderna, Inc.
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (97.4%); - grant revenue (1.4%); - revenue from collaboration agreements (1.2%). At the end of 2023, the group possessed a portfolio of 41 products in clinical development, of which 6 in phase III, 12 in phase II and 18 in phase I, and 5 products in preclinical development. Net sales are distributed geographically as follows: the United States (27.7%), Europe (19.8%) and other (52.5%).
Employees
5,600
Calendar
More about the company